New Biotechnology ETF Could Be a Stellar Second Half Idea

The Invesco Nasdaq Biotechnology ETF (IBBQ) is just a few weeks old, but even with that rookie status, it could be a stellar second half idea. On the back of the Food and Drug Administration (FDA) conditionally approving Biogen’s (NASDAQ: BIIB) Alzheimer’s drug, Aduhelm, the Nasdaq...